NDT Plus Advance Access published online on January 19, 2008
NDT Plus, doi:10.1093/ndtplus/sfm045
| ||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Pyrexia of unknown origin in a haemodialysis patient
UCL Center for Nephrology, Hampstead Campus, Royal Free & University College Medical School, Rowland Hill Street, London NW3 2PF, UK
Correspondence: A. Davenport, UCL Center for Nephrology, Hampstead Campus, Royal Free & University College Medical School, Rowland Hill Street, London NW3 2PF, UK. E-mail: Andrew.davenport@royalfree.nhs.uk
Key Words: ethylene oxide haemodialysis pyrexia rigors
Received for publication December 3, 2007. Accepted for publication December 12, 2007.
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
The most common cause of pyrexial reactions in the haemodialysis patient remains bacterial infections. The incidence of infection is increased in the dialysis patient [1], particularly due to indwelling central venous catheters. Pyrexial reactions have been reported with microbacterial contamination of the dialysate [2], but these are now rare events, due to the regular testing of dialysate water.
Occasionally, patients may react to a component in the extracorporeal circuit. These reactions vary from local eczematous skin eruptions, to a variety of systemic reactions, ranging from headache to anaphylaxis [3].
A case of recurrent intra- and post-dialysis fevers is presented as a teaching case.
| Case |
|---|
A 45-year-old man, who emigrated from the Caribbean to the UK when aged 8 years, developed end-stage kidney disease in July 2003. He had completed a 2-year course of anti-tuberculous chemotherapy for pulmonary TB in 1972.
He was started on peritoneal
| Discussion |
|---|
| Teaching points |
|---|